Abiopharma

🔍 Greene Michelle D. (Executive)

Company: CARDINAL HEALTH INC (CAH)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Sold 2,500 shares of Common Shares at $234.57 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 19,480.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,952 shares of Common Shares at $235.68 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,528.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 3,512 shares of Common Shares at $236.31 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,016.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 686 shares of Common Shares at $237.25 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 10,330.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, 3, and 4 to this Form 4.
• F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.08 to $236.07, inclusive.
• F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.08 to $236.96, inclusive.
• F4: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.125 to $237.32, inclusive.